State Street’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,466
Closed -$20.4K 4338
2025
Q3
$20.4K Hold
4,466
﹤0.01% 4243
2025
Q2
$17.5K Hold
4,466
﹤0.01% 4210
2025
Q1
$18.1K Hold
4,466
﹤0.01% 4219
2024
Q4
$33.8K Hold
4,466
﹤0.01% 4170
2024
Q3
$108K Hold
4,466
﹤0.01% 3964
2024
Q2
$187K Buy
4,466
+450
+11% +$23.6K ﹤0.01% 3843
2024
Q1
$260K Hold
4,016
﹤0.01% 3814
2023
Q4
$182K Hold
4,016
﹤0.01% 3926
2023
Q3
$176K Hold
4,016
﹤0.01% 3974
2023
Q2
$292K Hold
4,016
﹤0.01% 3884
2023
Q1
$306K Buy
4,016
+300
+8% +$24.2K ﹤0.01% 3923
2022
Q4
$358K Hold
3,716
﹤0.01% 3883
2022
Q3
$419K Buy
3,716
+40
+1% +$4.65K ﹤0.01% 3844
2022
Q2
$466K Buy
3,676
+570
+18% +$50.1K ﹤0.01% 3851
2022
Q1
$217K Buy
3,106
+386
+14% +$26.8K ﹤0.01% 4349
2021
Q4
$195K Hold
2,720
﹤0.01% 4365
2021
Q3
$141K Buy
2,720
+1,340
+97% +$79.8K ﹤0.01% 4465
2021
Q2
$86K Buy
+1,380
New +$77.5K ﹤0.01% 4387

Other funds holding PRPH

State Street's PRPH Position: Q4 2025 in Review

State Street sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 4,466 shares — an estimated $20.4K sold.

State Street first reported a position in PRPH in Q2 2021 and held it in 18 quarters. The position peaked at $466K in Q2 2022. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

  • State Street reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
  • State Street sold 4,466 ProPhase Labs shares in Q4 2025, an estimated $20.4K.
  • State Street first reported a position in ProPhase Labs in Q2 2021 and held it in 18 quarters.
  • State Street's ProPhase Labs position peaked at $466K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on State Street's 13F filing for Q4 2025, filed 13 Feb 2026.